Literature DB >> 2139696

Acute lethal graft-versus-host reaction induced by major histocompatibility complex class II-reactive T helper cell clones.

P V Lehmann1, G Schumm, D Moon, U Hurtenbach, F Falcioni, S Muller, Z A Nagy.   

Abstract

T cell clones isolated from class II MHC-disparate MLR combinations, and specific for I-Ak and I-Ek molecules, respectively, are shown to induce acute lethal graft-vs-host disease in unirradiated recipients. Cytolytic and noncytolytic clones are equally efficient in this respect. The lethal disease is dependent on recognition of the stimulatory class II molecules in the host. The clones home to lungs and liver, and become activated in these organs as demonstrated by an in vivo thymidine incorporation assay. After activation, a severe vascular leak syndrome develops causing death of the recipients within 5 d after the injection of 5 x 10(6) to 10(7) cloned cells. The disease develops without the participation of secondary host-derived inflammatory mechanisms, such as mast cell degranulation, complement activation, and the release of prostaglandins, oxygen radicals, or proteolytic enzymes. The results raise the possibility that Th cells can directly influence vascular permeability, and control, thereby, the acute inflammatory reaction of blood vessels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139696      PMCID: PMC2187885          DOI: 10.1084/jem.171.5.1485

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  Ability of H-2 regions to induce graft-vs-host disease.

Authors:  J Klein; C L Chiang
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

2.  T cell subsets and graft-versus-host disease.

Authors:  R Korngold; J Sprent
Journal:  Transplantation       Date:  1987-09       Impact factor: 4.939

3.  The in vivo behavior of T cell clones: altered migration due to loss of the lymphocyte surface homing receptor.

Authors:  M O Dailey; W M Gallatin; I L Weissman
Journal:  J Mol Cell Immunol       Date:  1985

4.  In vitro secondary MLR. I. Kinetics of proliferation and specificity of in vitro primed responder cells.

Authors:  C G Fathman; D Collavo; S Davies; M Nabholz
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

5.  Fate of H2-activated T lymphocytes in syngeneic hosts. I. Fate in lymphoid tissues and intestines traced with 3H-thymidine, 125I-deoxyuridine and 51chromium.

Authors:  J Sprent
Journal:  Cell Immunol       Date:  1976-02       Impact factor: 4.868

6.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

7.  Clinical effects and toxicity of interleukin-2 in patients with cancer.

Authors:  M T Lotze; Y L Matory; A A Rayner; S E Ettinghausen; J T Vetto; C A Seipp; S A Rosenberg
Journal:  Cancer       Date:  1986-12-15       Impact factor: 6.860

8.  Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia.

Authors:  D J Peace; M A Cheever
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

9.  A high proportion of T lymphocytes that infiltrate H-2-incompatible heart allografts in vivo express genes encoding cytotoxic cell-specific serine proteases, but do not express the MEL-14-defined lymph node homing receptor.

Authors:  C Mueller; H K Gershenfeld; C G Lobe; C Y Okada; R C Bleackley; I L Weissman
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts.

Authors:  J Sprent; M Schaefer; E K Gao; R Korngold
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Induction of T helper cell subsets.

Authors:  M Röcken; K M Müller; C Hauser
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Induction of cutaneous graft-versus-host disease by local injection of unprimed T cells.

Authors:  K Kawai; Y Matsumoto; H Watanabe; M Ito; M Fujiwara
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

3.  Graft-versus-host resistance induced by class II major histocompatibility complex-specific T cell clones.

Authors:  P V Lehmann; K Drexler; M Tary-Lehmann; F Falcioni; U Hurtenbach; Z A Nagy
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

4.  Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras.

Authors:  M Tary-Lehmann; P V Lehmann; D Schols; M G Roncarolo; A Saxon
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

5.  Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood.

Authors:  M Tary-Lehmann; A Saxon
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

6.  High-Throughput GLP-Capable Target Cell Visualization Assay for Measuring Cell-Mediated Cytotoxicity.

Authors:  Anna Welter; Srividya Sundararaman; Ruliang Li; Ting Zhang; Alexey Y Karulin; Alexander Lehmann; Villian Naeem; Diana R Roen; Stefanie Kuerten; Paul V Lehmann
Journal:  Cells       Date:  2018-04-24       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.